Use of ceftolozane-tazobactam in a cystic fibrosis patient with multidrug-resistant pseudomonas infection and renal insufficiency.

Authors

Katie Stokem, Maine Medical Center
Jonathan B Zuckerman, Maine Medical Center
David P Nicolau
Minkey Wungwattana, Maine Medical Center
Edmund H Sears, Maine Medical CenterFollow

Document Type

Article

Publication Date

1-1-2018

Institution/Department

Critical Care; Pharmacy; Pulmonology

Journal Title

Respiratory medicine case reports

Abstract

We report the successful use of ceftolozane/tazobactam (C/T) to treat a pulmonary exacerbation in a 35 year old female, post lung transplant, with cystic fibrosis (CF), malnutrition, chronic kidney disease, and multi-drug resistant pseudomonas aeruginosa infection.

ISSN

2213-0071

First Page

8

Last Page

9

Recommended Citation

Stokem, Katie; Zuckerman, Jonathan B; Nicolau, David P; Wungwattana, Minkey; and Sears, Edmund H, "Use of ceftolozane-tazobactam in a cystic fibrosis patient with multidrug-resistant pseudomonas infection and renal insufficiency." (2018). MaineHealth Maine Medical Center. 421.
https://knowledgeconnection.mainehealth.org/mmc/421